Sensitive determination of nitrofurantoin in human plasma and urine by high-performance liquid chromatography.
A highly sensitive and selective HPLC method was developed and validated for the determination of nitrofurantoin in human plasma and urine. The method involves the liquid-liquid extraction of drug and internal standard from plasma with ethyl acetate followed by evaporation and reconstitution in mobile phase. Urine samples were simply diluted with purified water. UV detection was done at 370 nm. The limit of quantification for nitrofurantoin in plasma was 0.010 micrograms/ml. In urine nitrofurantoin could be quantified down to 0.380 microgram/ml. Linearity was proven over the whole calibration range in plasma (2.48-0.0100 microgram/ml) as well as in urine (187 micrograms/ml-0.380 microgram/ml). The method was validated according to Good Laboratory Practice guidelines and its suitability was demonstrated by analysis of samples from a pharmacokinetic study.
Muth
P
P
Medical-Biological Development Heumann Pharma, Nürnberg, Germany.
Metz
R
R
Siems
B
B
Bolten
W W
WW
Vergin
H
H
D000892:Anti-Infective Agents, Urinary / Q000032:analysis* / Q000097:blood / Q000652:urine; D002138:Calibration; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007202:Indicators and Reagents; D009582:Nitrofurantoin / Q000032:analysis* / Q000097:blood / Q000652:urine; D011786:Quality Control; D012015:Reference Standards; D015203:Reproducibility of Results; D013056:Spectrophotometry, Ultraviolet
D000892:Anti-Infective Agents, Urinary; D007202:Indicators and Reagents; D009582:Nitrofurantoin